Is a one-time screening program cost-effective in an asymptomatic population with a high prevalence of carotid stenosis?
A one-time screening program for asymptomatic carotid stenosis may be cost-effective in high-prevalence populations, but annual screening is detrimental.
The cost-effectiveness of a one-time screening program for an asymptomatic population with a high prevalence of carotid stenosis may be cost-effective. Annual screening is detrimental. The most sensitive variables in this simulation model were long-term stroke risk reduction after surgery and annual discount rate for accumulated costs and QALYs.
Derdeyn et al. (Fri,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: